LEADER 02808oam 2200577I 450 001 9910800095803321 005 20230802005159.0 010 $a0-429-16725-3 010 $a1-280-48789-5 010 $a9786613583123 010 $a1-4441-4982-2 024 7 $a10.1201/b13322 035 $a(CKB)2550000000101751 035 $a(EBL)967157 035 $a(OCoLC)799764130 035 $a(SSID)ssj0000681765 035 $a(PQKBManifestationID)11406736 035 $a(PQKBTitleCode)TC0000681765 035 $a(PQKBWorkID)10663257 035 $a(PQKB)11713799 035 $a(OCoLC)794930564 035 $a(MiAaPQ)EBC967157 035 $a(Au-PeEL)EBL967157 035 $a(CaPaEBR)ebr10563883 035 $a(CaONFJC)MIL358312 035 $a(EXLCZ)992550000000101751 100 $a20180331d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aSarcoidosis /$fDonald N. Mitchell. [et al.] 210 1$aLondon :$cHodder Arnold,$d2012. 215 $a1 online resource (488 p.) 300 $aDescription based upon print version of record. 311 $a0-340-99211-5 320 $aIncludes bibliographical references and index. 327 $apt. 1. Historical survey, definition and epidemiology -- pt. 2. Etiology, pathology, immunology and genetics -- pt. 3. Investigations -- pt. 4. The heart, pulmonary hypertension, the upper respiratory tract, the airways, and pulmonary fibrosis -- pt. 5. The liver and GI tract, spleen, blood and bone marrow, nervous system, renal and calcium metabolism, and psychiatric aspects -- pt. 6. Skin, eyes, joints and skeletal muscles, superficial lymphadenopathy, and endocrine glands -- pt. 7. Beryllium disease, HIV, and neoplasms -- pt. 8. Childhood sarcoid -- pt. 9. Diagnosis and treatment -- pt. 10. Surgical investigation, management and future research. 330 $aSarcoidosis represents a major challenge for physicians-not just in respiratory medicine, but across a range of specialties. This book, with a multidisciplinary authorship of the highest standard, presents the most up-to-date thinking on all aspects of the condition, from epidemiology to clinical manifestations and treatment options. Full coverage is given to both respiratory and non-respiratory aspects. The basic science that underlies the disease and its progression is evaluated in detail, and placed into its correct clinical context. Possible future advances are covered in a concluding sect 606 $aSarcoidosis 615 0$aSarcoidosis. 676 $a616.429 701 $aMitchell$b Donald$0168023 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910800095803321 996 $aSarcoidosis$93876689 997 $aUNINA LEADER 01584nam 22004093 450 001 996678678703316 005 20250920060326.0 010 $a3-032-04624-6 035 $a(MiAaPQ)EBC32301881 035 $a(Au-PeEL)EBL32301881 035 $a(CKB)40970632800041 035 $a(EXLCZ)9940970632800041 100 $a20250920d2025 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDocument Analysis and Recognition - ICDAR 2025 $e19th International Conference, Wuhan, China, September 16-21, 2025, Proceedings, Part III 205 $a1st ed. 210 1$aCham :$cSpringer,$d2025. 210 4$dİ2026. 215 $a1 online resource (984 pages) 225 1 $aLecture Notes in Computer Science Series ;$vv.16025 311 08$a3-032-04623-8 330 $aThe 5-volume set LNCS 16023 - 16027 constitutes the proceedings of the 19th International Conference on Document Analysis and Recognition, ICDAR 2025, which took place in Wuhan, China, during September 2025.  The total of 142 full papers included in the proceedings was carefully reviewed and selected from 314 submissions. 410 0$aLecture Notes in Computer Science Series 700 $aYin$b Xu-Cheng$01735032 701 $aKaratzas$b Dimosthenis$01849866 701 $aLopresti$b Daniel$0899206 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996678678703316 996 $aDocument Analysis and Recognition - ICDAR 2025$94442689 997 $aUNISA